A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Zhou, Meng ^a,b   Guo, Maoni ^a   He, Dongfeng ^a   Wang, Xiaojun ^a   Cui, Yinqiu ^b   Yang, Haixiu ^a   Hao, Dapeng ^a   Sun, Jie ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Long non coding RNA; Non small cell lung cancer; Overall survival; Signature

Indexed keywords

LONG UNTRANSLATED RNA;

AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FUNCTIONAL ASSESSMENT; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETIC RISK; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LOW RISK PATIENT; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR PROBE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RISK ASSESSMENT; RNA TRANSCRIPTION; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; VALIDATION PROCESS; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; OPEN READING FRAME; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL ANALYSIS;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; DATABASES, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OPEN READING FRAMES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; RNA, LONG NONCODING; ROC CURVE; SURVIVAL ANALYSIS;

EID: 84937040431     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0556-3     Document Type: Article

References (53)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
2. She J, Yang P, Hong Q, Bai C (2013) Lung cancer in China: challenges and interventions. Chest 143(4):1117-1126
3. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K et al (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455(7216):1069-1075
4. Cheetham SW, Gruhl F, Mattick JS, Dinger ME (2013) Long noncoding RNAs and the genetics of cancer. Br J Cancer 108(12):2419-2425
5. Ma L, Bajic VB, Zhang Z (2013) On the classification of long non-coding RNAs. RNA Biol 10(6):925-933
6. Fatica A, Bozzoni I (2014) Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15(1):7-21. doi: 10.1038/nrg3606
7. Wang KX, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43(6):904-914. doi: 10.1038/hr.2015.26
8. Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505(7483):344-352
9. Kornienko AE, Guenzl PM, Barlow DP, Pauler FM (2013) Gene regulation by the act of long non-coding RNA transcription. BMC Biol 11:59
10. Maass PG, Luft FC, Bahring S (2014) Long non-coding RNA in health and disease. J Mol Med 92(4):337-346. doi: 10.1007/s00109-014-1131-8
11. Qiu MT, Hu JW, Yin R, Xu L (2013) Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol 34(2):613-620
12. Prensner JR, Chinnaiyan AM (2011) The emergence of lncRNAs in cancer biology. Cancer Discov 1(5):391-407
13. Tang JY, Lee JC, Chang YT, Hou MF, Huang HW, Liaw CC et al (2013) Long noncoding RNAs-related diseases, cancers, and drugs. Sci World J 2013:943539. doi: 10.1155/2013/943539
14. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ et al (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464(7291):1071-1076
15. Ge X, Chen Y, Liao X, Liu D, Li F, Ruan H et al (2013) Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer. Med Oncol 30(2):588
16. Hauptman N, Glavac D (2013) Long non-coding RNA in cancer. Int J Mol Sci 14(3):4655-4669
17. Zhang H, Chen Z, Wang X, Huang Z, He Z, Chen Y (2013) Long non-coding RNA: a new player in cancer. J Hematol Oncol 6:37
18. Zhang W, Huang C, Gong Z, Zhao Y, Tang K, Li X et al (2013) Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol 44(5):545-554
19. Li J, Chen Z, Tian L, Zhou C, He MY, Gao Y et al (2014) LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut 63(11):1700-1710
20. Chen J, Wang R, Zhang K, Chen LB (2014) Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets. J Cell Mol Med 18(12):2425-2436. doi: 10.1111/jcmm.12431
21. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM et al (2003) MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22(39):8031-8041
22. White NM, Cabanski CR, Silva-Fisher JM, Dang HX, Govindan R, Maher CA (2014) Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer. Genome Biol 15(8):429
23. Nie FQ, Zhu Q, Xu TP, Zou YF, Xie M, Sun M et al (2014) Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion. Tumour Biol 35(8):7587-7594. doi: 10.1007/s13277-014-2009-7
24. Zhang XQ, Sun S, Lam KF, Kiang KM, Pu JK, Ho AS et al (2013) A long non-coding RNA signature in glioblastoma multiforme predicts survival. Neurobiol Dis 58:123-131
25. Hu Y, Chen HY, Yu CY, Xu J, Wang JL, Qian J et al (2014) A long non-coding RNA signature to improve prognosis prediction of colorectal cancer. Oncotarget 5(8):2230-2242
26. Meng J, Li P, Zhang Q, Yang Z, Fu S (2014) A four-long non-coding RNA signature in predicting breast cancer survival. J Exp Clin Cancer Res 33(1):84
27. Zhao W, Luo J, Jiao S (2014) Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications. Sci Rep 4:6591
28. Yang J, Lin J, Liu T, Chen T, Pan S, Huang W et al (2014) Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer 85(2):110-115
29. Botling J, Edlund K, Lohr M, Hellwig B, Holmberg L, Lambe M et al (2013) Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clin Cancer Res Off J Am Assoc Cancer Res 19(1):194-204. doi: 10.1158/1078-0432.CCR-12-1139
30. Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, Iwakawa R et al (2012) Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res 72(1):100-111. doi: 10.1158/0008-5472.CAN-11-1403
31. Der SD, Sykes J, Pintilie M, Zhu CQ, Strumpf D, Liu N et al (2014) Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 9(1):59-64. doi: 10.1097/JTO.0000000000000042
32. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31(4):e15
33. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 4(2):249-264
34. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F et al (2012) GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22(9):1760-1774. doi: 10.1101/gr.135350.111
35. Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO et al (2012) Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis 48(1):1-8
36. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D et al (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350(18):1828-1837
37. da Huang W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1):1-13
38. Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R et al (2011) Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. Int J Cancer 129(2):355-364. doi: 10.1002/ijc.25704
39. Guo NL, Wan YW (2012) Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival. Artif Intell Med 55(2):97-105
40. Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 56(2):337-344
41. Merico D, Isserlin R, Stueker O, Emili A, Bader GD (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 5(11):e13984. doi: 10.1371/journal.pone.0013984
42. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498-2504. doi: 10.1101/gr.1239303
43. Kratz JR, Jablons DM (2009) Genomic prognostic models in early-stage lung cancer. Clin Lung Cancer. 10(3):151-157
44. Zhu CQ, Pintilie M, John T, Strumpf D, Shepherd FA, Der SD et al (2009) Understanding prognostic gene expression signatures in lung cancer. Clin Lung Cancer. 10(5):331-340
45. Gibb EA, Vucic EA, Enfield KS, Stewart GL, Lonergan KM, Kennett JY et al (2011) Human cancer long non-coding RNA transcriptomes. PLoS One 6(10):e25915
46. Su X, Malouf GG, Chen Y, Zhang J, Yao H, Valero V et al (2014) Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes. Oncotarget. 5(20):9864-9876
47. Du Z, Fei T, Verhaak RG, Su Z, Zhang Y, Brown M et al (2013) Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol 20(7):908-913
48. Subramanian J, Simon R (2010) Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst 102(7):464-474
49. Skarin AT, Herbst RS, Leong TL, Bailey A, Sugarbaker D (2001) Lung cancer in patients under age 40. Lung Cancer 32(3):255-264
50. Hsu CL, Chen KY, Shih JY, Ho CC, Yang CH, Yu CJ et al (2012) Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors. BMC Cancer 12:241
51. Chen KY, Chang CH, Yu CJ, Kuo SH, Yang PC (2005) Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma. Cancer 103(12):2566-2574
52. Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow LQ, Downey RJ et al (2013) Small cell lung cancer. J Natl Compr Canc Netw 11(1):78-98
53. Hangauer MJ, Vaughn IW, McManus MT (2013) Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet 9(6):e1003569